Editorial*EXCLUSIVE* Jessica Lange is seen being pushed in her wheelchair by son Samuel during a very sighting for the 36 year old musician whom she shares with the late Sam Shepard. *Web Must Call For Pricing*
EditorialApril Crawford of Oliver Springs, Tenn., turned to GoFundMe to help pay for a drug that could slow her multiple sclerosis. The drug, Mavenclad, has a list price of $194,000 a year. (Jessica Tezak/The New York Times)
EditorialEXCLUSIVE: Ioan Gruffudd and his girlfriend Bianca Wallace show their relationship is still going strong as they arrive together at LAX airport.
EditorialJoshua Cohen, left, and Justin Klee, the founders of Amylyx, outside their offices in Cambridge, Mass.,on Aug 27, 2020. (Cody O'Loughlin/The New York Times)
EditorialAndrea Peet, who lives with amyotrophic lateral sclerosis, recovers after participating in the Brooklyn marathon on April 24, 2022. (Hilary Swift/The New York Times)
EditorialThe snowboarder Cecile Hernandez of France, who has multiple sclerosis, competes in a qualification run at the Beijing Paralympics, in Zhangjiakou, China, March 6, 2022. (Chang W. Lee/The New York Times)
EditorialBrian Wallach, who has amyotrophic lateral sclerosis, and his wife, Sandra Abrevaya, look over the website of Synapticure, the company they started, at their home in Kenilworth, Ill., on Jan. 15, 2022. (Taylor Glascock/The New York Times)
EditorialFormer football player, commentator and author Tim Green, 57, at his home in Skaneateles, N.Y., on Sept. 30, 2021. (Heather Ainsworth/The New York Times)
EditorialRebecca Luker, who died in December 2020 of amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig’s disease, performs at 54 Below in New York, May 17, 2013. (Jennifer Taylor/The New York Times)
EditorialGail Clayton, a multiple sclerosis clinical nurse is given the Pfizer-BioNTech COVID-19 vaccine in Cardiff, Wales, on Tuesday, Dec. 8, 2020. (Andrew Testa/The New York Times)
EditorialAmylyx co-founders Justin Klee, left, and Joshua Cohen outside of their offices in Cambridge, Mass., Aug. 27, 2020. (Cody O'Loughlin/The New York Times)
EditorialMike Teal, who is taking an experimental drug to slow the progression of amyotrophic lateral sclerosis (ALS), leaves his home in Tallahassee, Fla., Aug. 27, 2020. (Aileen Perilla/The New York Times)